CRVS - Corvus Pharmaceuticals, Inc.
16.06
-1.780 -11.083%
Share volume: 1,274,186
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$17.84
-1.78
-0.10%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-12-2024 | 03-25-2025 | 05-08-2025 | 08-07-2025 | 11-04-2025 | |
| Cash flow financing | 0.000 | 30.370 M | 50.000 K | 18.608 M | 279.000 K | 35.770 M | 360.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 50.000 K | 18.608 M | 279.000 K | 35.770 M | 360.000 K | |
| Cash flow | -5.164 M | 7.385 M | -10.161 M | 4.060 M | -3.741 M | 9.692 M | -11.824 M | |
| Net income | -5.701 M | -4.262 M | -40.217 M | -12.113 M | 15.193 M | -7.998 M | -10.157 M | |
| Depreciation | 23.000 K | 21.000 K | 21.000 K | 20.000 K | 22.000 K | 29.000 K | 28.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -7.000 K | -17.504 M | -3.890 M | -6.083 M | 4.243 M | -20.301 M | -2.618 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 36.000 K | 113.000 K | 0.000 | |
| Cash Change | -5.164 M | 7.385 M | -10.161 M | 4.060 M | -3.741 M | 9.692 M | -11.824 M |